Forma Therapeutics to Participate in Upcoming Investor Conferences
17 February 2021 - 11:05PM
Business Wire
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a
clinical-stage biopharmaceutical company focused on rare
hematologic diseases and cancers, today announced that company
management will participate in three upcoming investor
conferences:
- The SVB Leerink 10th Annual Global Healthcare Conference taking
place Feb. 22-26. Forma will present on Wednesday, Feb. 24 at 1:40
p.m. Eastern Standard Time (EST).
- The H.C. Wainwright Global Life Sciences Conference taking
place March 9-10. Forma will present on Tuesday, March 9 at 7:00
a.m. EST.
- The Oppenheimer 31st Annual Healthcare Conference taking place
March 16-17. Forma will present on Wednesday, March 17 at 8:40 a.m.
EST.
Webcasts of the conference presentations will be available in
the “News & Investors” section of Forma’s website at
www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company
focused on the research, development and commercialization of novel
therapeutics to transform the lives of patients with rare
hematologic diseases and cancers. Our R&D engine combines deep
biology insight, chemistry expertise and clinical development
capabilities to create drug candidates with differentiated
mechanisms of action focused on indications with high unmet need.
Our work has generated a broad proprietary portfolio of programs
with the potential to provide profound patient benefit. For more
information, please visit www.FormaTherapeutics.com or follow us on
Twitter @FORMAInc and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210217005230/en/
Media Contact: Kari Watson, +1 781-235-3060 MacDougall
kwatson@macbiocom.com
Investor Contact: Mario Corso, +1 781-366-5726 Forma
Therapeutics, Inc. mcorso@formatherapeutics.com
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Forma Therapeutics Holdings Inc (NASDAQ): 0 recent articles
More Forma Therapeutics Holdings Inc News Articles